SMTL ID : 6f3g.1 (1 other biounit)

IRAK4 IN COMPLEX WITH inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.37 Å

Oligo State

monomer

Ligands

1 x CJN: ~{N}4,~{N}4-dimethyl-~{N}1-(5-propan-2-ylpyrrolo[3,2-d]pyrimidin-4-yl)cyclohexane-1,4-diamine(Non-covalent)

CJN.1: 11 residues within 4Å: Chain A: M.29, G.30, V.37, A.48, Y.99, V.100, Y.101, M.102, D.109, L.155, S.165 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.37, A:A.48, A:Y.99, A:Y.99, A:L.155, A:L.155 Hydrogen bonds: A:M.102 Salt bridges: A:D.109

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Degorce, S.L. et al., Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4. Bioorg. Med. Chem. (2018)

Release Date

2018-05-23

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence